Compare two medicines for long-term pain in real life
Part of Pain clinical trials.
This trial compares two types of medicines—anti-convulsants and anti-depressants—for people with persistent pain lasting more than 3 months. It aims to find out which option works better in everyday care and for which patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- Your pain has lasted more than 3 months
- Your pain specialist thinks an anti-convulsant or an anti-depressant could be used to treat your pain
- Your doctor feels there isn’t a clear “best choice” between those two medicine types for you
- You are willing to take part in the study (you do not refuse)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different ways to help people manage chronic pain without using medications. Over 12 months, you'll use a smartphone app and learn strategies to feel better and have more control over your pain.
This trial tests different treatments to help people with long-term (chronic) pain and severe insomnia sleep better. It’s looking at three options—one medicine (lemborexant) compared with existing sleep medicines (zopiclone and clonidine)—and whether they improve sleep when non-medicine sleep strategies haven’t worked.
This study compares two non-drug treatments—mindfulness training and cognitive-behavioral therapy—to see which helps adults with chronic pain better. Both aim to reduce pain and improve quality of life.
This study asks people with chronic pain about their preferences and experiences. Your answers will help doctors understand what matters most to patients like you.
This study compares two ways of treating long-term muscle and joint pain: one focuses on understanding pain and coping with it, the other on improving daily function. It aims to find which approach helps people who haven't gotten relief from other treatments.
This study tests how a new pain medication interacts with another pain drug. It aims to see if combining them is safe and how it affects pain relief in people with ongoing pain that is not caused by cancer.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.